News for Healthier Living

Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia

The U.S. Food and Drug Administration has approved a new drug to treat an aggressive form of leukemia, based on the results of a clinical trial co-led by Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center.

December 2, 2025


December 2 2025

December 1 2025

November 30 2025

November 29 2025

November 28 2025

November 27 2025

November 26 2025

November 25 2025

November 24 2025

November 23 2025

November 22 2025

November 21 2025

November 20 2025

November 19 2025